Accès ouvert
2025
article
OpenAlex
Rebecca A. Deek, Jongmyung Kim, Ritesh Kumar, Benjamin D. Medina et autres
INTRODUCTION: Treatment of metastatic disease is rapidly evolving with local therapies increasingly being used in patients with oligometastasis. Better personalization is needed to appropriate select patients for these interventions. We attempted to better understand clinical features and genomic features of oligometastatic nonsmall …
us, tr
(code pays fourni par la source)
2025
article
OpenAlex
Su‐Bin Lee, Benjamin D. Medina, Ashley L. McCormack, Richard Lazzaro
us
(code pays fourni par la source)
2025
article
OpenAlex
Matthew P. Deek, Eshan U. Patel, Benjamin D. Medina, Ioannis Kontopidis et autres
e20676 Background: Treatment of oligometastatic non-small cell lung cancer (omNSCLC) is evolving with increasing use of local therapies to consolidate disease. Our molecular understanding is also improving with better ability to target genetically identified driver mutations. In non-metastatic NSCLC, combined approaches of …
us
(code pays fourni par la source)
2024
article
OpenAlex
Subin Lee, Benjamin D. Medina, Richard Lazzaro
us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Matthew J. Bott, Nicolas Toumbacaris, Kay See Tan, Bryan Husta et autres
us
(code pays fourni par la source)
Accès ouvert
2024
other
OpenAlex
Mark S. Etherington, Andrew N. Hanna, Benjamin D. Medina, Mengyuan Liu et autres
Viability of HG129 cells or T1 GIST cells after 24 hours of (A, B) human IL17a or (C, D) anti-human IL17Ra. Representative of 2 separate experiments with experimental groups in triplicate. Data represent mean ± SEM; p values were calculated using a …
Accès ouvert
2024
other
OpenAlex
Mark S. Etherington, Andrew N. Hanna, Benjamin D. Medina, Mengyuan Liu et autres
(A) Prevalence of IL17A+ γδ T cells in the spleens of KitV558Δ/+ mice after vehicle or imatinib treatment for 1 week. (B) Relative expression of Il6 by PCR of bulk KitV558Δ/+ tumors after 1 week of vehicle or imatinib. (C) Tumor weight …
Accès ouvert
2024
other
OpenAlex
Mark S. Etherington, Andrew N. Hanna, Benjamin D. Medina, Mengyuan Liu et autres
(A) Prevalence of IL17A+ γδ T cells in the spleens of KitV558Δ/+ mice after vehicle or imatinib treatment for 1 week. (B) Relative expression of Il6 by PCR of bulk KitV558Δ/+ tumors after 1 week of vehicle or imatinib. (C) Tumor weight …
Accès ouvert
2024
other
OpenAlex
Mark S. Etherington, Andrew N. Hanna, Benjamin D. Medina, Mengyuan Liu et autres
Notable Module 3 genes
Accès ouvert
2024
other
OpenAlex
Mark S. Etherington, Andrew N. Hanna, Benjamin D. Medina, Mengyuan Liu et autres
Abstract γδ T cells are a rare but potent subset of T cells with pleiotropic functions. They commonly reside within tumors but the response of γδ T cells to tyrosine kinase inhibition is unknown. To address this, we studied a genetically engineered …
Accès ouvert
2024
other
OpenAlex
Mark S. Etherington, Andrew N. Hanna, Benjamin D. Medina, Mengyuan Liu et autres
Supplemental Figure S2. Relative expression on a per cell basis in KitV558Δ/+ tumors of (A) Trdv4 and (B) multiple genes known to be members of the SCART1+ γδ T cell phenotype. Dot plots represent scRNAseq data of γδ T cells from 6 …
Accès ouvert
2024
other
OpenAlex
Mark S. Etherington, Andrew N. Hanna, Benjamin D. Medina, Mengyuan Liu et autres
Viability of HG129 cells or T1 GIST cells after 24 hours of (A, B) human IL17a or (C, D) anti-human IL17Ra. Representative of 2 separate experiments with experimental groups in triplicate. Data represent mean ± SEM; p values were calculated using a …